Publications by authors named "L M Stamm"

Transgender and gender-diverse (TGD) populations experience health disparities across all areas of health care due to issues of bias, discrimination, and structural barriers to care. Existing literature on cancer screening in TGD populations demonstrates significant gaps in care; for example, transgender men receive Pap smears at lower rates than cisgender women. Because of known disparities in cancer screening, and gaps in our understanding in terms of diagnosis, treatment, and survivorship, the authors conducted a rapid review of the literature to examine cancer care continuum (screening, treatment, and survivorship) disparities among TGD persons.

View Article and Find Full Text PDF

Objectives: This qualitative study explored the beliefs and values influencing healthcare providers' delivery of gender-affirming care (GAC) to transgender and gender-diverse (TGD) youth amidst current social and political dynamics.

Methods: The study PI conducted 43 semi-structured interviews with providers across states with varying GAC legislation. Responses from 41 providers were analyzed in this paper.

View Article and Find Full Text PDF

Background: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease among infants and young children worldwide, especially in low- and middle-income countries (LMICs). RSM01 is a novel, highly potent, half-life-extended anti-RSV monoclonal antibody (mAb) candidate primarily being developed for LMICs. Here we present the preclinical characterisation and results of a phase 1 trial of RSM01.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the lack of effective treatments for gastrointestinal (GI) symptoms in patients with systemic sclerosis (SSc) and examined the impact of immunosuppressive therapy on these symptoms.
  • Researchers analyzed 209 SSc patients and found that those undergoing immunosuppressive therapy experienced less severe GI symptoms, as measured by a specialized scoring tool, compared to those not receiving this treatment.
  • The findings suggest immunosuppressants may improve GI manifestations in SSc, but further confirmation through randomized clinical trials is needed.
View Article and Find Full Text PDF

Background: Refractory (RSE) and super-refractory status epilepticus (SRSE) are serious neurological conditions requiring aggressive management. Beyond anesthetic agents, there is a lack of evidence guiding management in these patients. This systematic review and individual participant data meta-analysis (IPDMA) seeks to evaluate and compare the currently available surgical techniques for the acute treatment of RSE and SRSE.

View Article and Find Full Text PDF